FDA Issues Final Guidance on Protecting Patients From Potentially Harmful Compounded Drugs in Insanitary Conditions
Patrizia Cavazzoni MD, director of the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA), issued the following statement today: “Protecting patients from exposure to poor…